Frequent coauthors D.A. Bradley 2 Mohamed A. Bedaiwy 2 Andrea S. Lukes 2 R Liu 2 Hugh S. Taylor 2 Kristof Chwalisż 2 LD Bradley 1 Ozgul Muneyyirci‐Delale 1 Sandra Hurtado 1 Ayman Al‐Hendy 1
article 2019 Effect of Fibroid Location and Size on Efficacy of Elagolix: Results from Phase 3 Clinical Trials ·doi:10.1016/j.jmig.2019.09.666
article 2019 Phase 3 Trial Results: Efficacy and Safety of Elagolix in a Subset of Women with Uterine Fibroids and Adenomyosis ·doi:10.1016/j.jmig.2019.09.580
article 2018 Efficacy and safety of elagolix in a subgroup of women with uterine fibroids and adenomyosis: results from a phase 2 trial ·doi:10.1016/j.fertnstert.2018.07.186
article 2018 Efficacy and Safety of Elagolix in a Subgroup of Women with Uterine Fibroids and Adenomyosis: Results from a Phase 2 Trial ·doi:10.1016/j.jmig.2018.09.175